- Home
- ROIV vs WSC Comparison
ROIV vs WSC Comparison
Compare ROIV & WSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | WSC |
|---|---|---|
| Founded | 2014 | 1944 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Corporate Leasing Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 3.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | WSC |
|---|---|---|
| Price | $22.87 | $19.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $21.94 | ★ $25.43 |
| AVG Volume (30 Days) | ★ 6.7M | 4.0M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.37% |
| EPS Growth | N/A | ★ 816.06 |
| EPS | N/A | ★ 1.20 |
| Revenue | $20,329,000.00 | ★ $2,317,990,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $376.94 | N/A |
| P/E Ratio | ★ N/A | $17.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $14.91 |
| 52 Week High | $22.45 | $39.61 |
Technical Indicators
Market Signals| Indicator | ROIV | WSC |
|---|---|---|
| Relative Strength Index (RSI) | 71.09 | 46.44 |
| Support Level | $20.14 | $20.08 |
| Resistance Level | $21.48 | $21.45 |
| Average True Range (ATR) | 0.77 | 0.93 |
| MACD | 0.09 | 0.08 |
| Stochastic Oscillator | 88.97 | 11.45 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About WSC WillScot Mobile Mini Holdings Corp.
WillScot Holdings Corp designs, delivers, and services onsite, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company includes modular office complexes, mobile offices, portable storage containers, and others.